Skip to content

Cytopat: what changed

BE 0423.639.481NACE 86.910, Medical imaging and medical laboratoriesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€20,157
2024 · -€24,856+€45,012
Equity
€438,730
2024 · €430,074+€8,657
Cash
€23,137
2024 · €28,479-€5,342
Balance sheet total
€597,026
2024 · €595,936+€1,089

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€7,078

    up €7,078 (+3.7%), from €192,687 to €199,766

    of which Trade receivables: +€11,171

  • Deferred charges and accrued income -€6,451

    down €6,451 (-29.7%), from €21,720 to €15,268

Equity and liabilities
  • Current portion of long-term debt -€24,636

    down €24,636 (-84.7%), from €29,071 to €4,434

  • Tax, wage and social debts +€14,382

    up €14,382 (+21.9%), from €65,649 to €80,031

    of which Remuneration and social security: +€11,806

  • Other debts +€9,327

    up €9,327, from €0 to €9,327

  • Accrued charges and deferred income -€8,944

    down €8,944 (-74.7%), from €11,969 to €3,026

  • Profit (loss) carried forward +€8,657

    up €8,657 (+18.8%), from -€46,110 to -€37,454

Income statement
  • Gross operating margin +€123,017

    up €123,017 (+15.2%), from €811,628 to €934,645

  • Staff costs +€105,888

    up €105,888 (+13.9%), from €761,837 to €867,725

  • Other operating charges -€33,416

    down €33,416 (-70.1%), from €47,654 to €14,238

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€24,856
Gross operating margin +€123,017
Staff costs -€105,888
Depreciation -€6,435
Other operating charges +€33,416
Other operating items +€2,333
Financial income +€5,267
Financial charges +€246
Taxes -€6,943
Result 2025 €20,157
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€65,469
Investment -€30,240
Financing -€40,571
Cash 2024 €28,479
Net result for the year +€20,157
Depreciation +€24,436
Receivables within one year -€7,078
Deferred charges and accrued income +€6,451
Trade debts +€6,737
Tax, wage and social debts +€14,382
Other debts +€9,327
Accrued charges and deferred income -€8,944
Investment in fixed assets (net) -€28,338
Current investments -€1,902
Debts after one year -€4,434
Current portion of long-term debt -€24,636
Contributions, distributions and other -€11,500
Cash 2025 €23,137
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €595,936 €597,026 +€1,089 +0.2%
Fixed assets 21/28 €236,419 €240,321 +€3,902 +1.7%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €233,487 €237,389 +€3,902 +1.7%
Land and buildings 22 €209,546 €203,182 -€6,364 -3.0%
Plant, machinery and equipment 23 €18,215 €7,643 -€10,573 -58.0%
Furniture and vehicles 24 €2,534 €20,335 +€17,802 +703%
Other tangible fixed assets 26 €3,192 €6,229 +€3,036 +95.1%
Financial fixed assets 28 €2,932 €2,932 = 0.0%
Current assets 29/58 €359,517 €356,705 -€2,812 -0.8%
Amounts receivable within one year 40/41 €192,687 €199,766 +€7,078 +3.7%
Trade receivables 40 €187,753 €198,923 +€11,171 +5.9%
Other amounts receivable 41 €4,935 €842 -€4,092 -82.9%
Current investments 50/53 €116,631 €118,534 +€1,902 +1.6%
Cash at bank and in hand 54/58 €28,479 €23,137 -€5,342 -18.8%
Deferred charges and accrued income 490/1 €21,720 €15,268 -€6,451 -29.7%
Total equity and liabilities 10/49 €595,936 €597,026 +€1,089 +0.2%
Equity 10/15 €430,074 €438,730 +€8,657 +2.0%
Contributions 10/11 €60,000 €60,000 = 0.0%
Reserves 13 €416,184 €416,184 = 0.0%
Tax-exempt reserves 132 €159 €159 = 0.0%
Distributable reserves 133 €416,025 €416,025 = 0.0%
Profit (loss) carried forward 14 -€46,110 -€37,454 +€8,657 +18.8%
Amounts payable 17/49 €165,863 €158,295 -€7,567 -4.6%
Amounts payable after more than one year 17 €10,698 €6,263 -€4,434 -41.5%
Financial debts 170/4 €10,698 €6,263 -€4,434 -41.5%
Amounts payable within one year 42/48 €143,196 €149,006 +€5,810 +4.1%
Current portion of amounts payable after more than one year 42 €29,071 €4,434 -€24,636 -84.7%
Trade debts 44 €48,476 €55,213 +€6,737 +13.9%
Suppliers 440/4 €48,476 €55,213 +€6,737 +13.9%
Taxes, remuneration and social security 45 €65,649 €80,031 +€14,382 +21.9%
Taxes 450/3 - €2,577 +€2,577
Remuneration and social security 454/9 €65,649 €77,455 +€11,806 +18.0%
Other amounts payable 47/48 €0 €9,327 +€9,327
Accrued charges and deferred income 492/3 €11,969 €3,026 -€8,944 -74.7%
Non-recurring operating income 76A €28 €0 -€28 -100%
Remuneration, social security and pensions 62 €761,837 €867,725 +€105,888 +13.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,002 €24,436 +€6,435 +35.7%
Other operating charges 640/8 €47,654 €14,238 -€33,416 -70.1%
Non-recurring operating charges 66A €10,122 €7,789 -€2,333 -23.0%
Gross operating margin 9900 €811,628 €934,645 +€123,017 +15.2%
Operating profit (loss) 9901 -€25,987 €20,456 +€46,443
Financial income 75/76B €4,354 €9,621 +€5,267 +121%
Recurring financial income 75 €4,354 €9,621 +€5,267 +121%
Financial charges 65/66B €2,623 €2,378 -€246 -9.4%
Recurring financial charges 65 €2,623 €2,378 -€246 -9.4%
Profit (loss) for the period before taxes 9903 -€24,256 €27,699 +€51,956
Income taxes 67/77 €599 €7,543 +€6,943 +1,159%
Profit (loss) for the period 9904 -€24,856 €20,157 +€45,012
Profit (loss) for the period to be appropriated 9905 -€24,856 €20,157 +€45,012

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€438,730 to €438,730

Midpoint €438,730 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €438,730
Indication €438,730

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€438,730
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€438,730

Capitalised earnings

net result for the year (9904)
2025
€20,157
excluding non-recurring income and charges
€27,946
2024
-€24,856
excluding non-recurring income and charges
-€14,761
2023
-€21,255
2022
€12,275
2021
-€2,856
Average result, excluding non-recurring income and charges
-€2,690
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.